首页 > 市场调查报告书 > 医疗设备

麻醉

市场调查报告书

商品编码

1606500

全球麻醉一次性用品市场 - 2024-2031

Global Anesthesia Disposables Market - 2024-2031

出版日期: 2024年12月04日 | 出版商:

DataM Intelligence | 英文 176 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

概述

2023年，全球麻醉一次性用品市场规模达11.2亿美元，预计2031年将达到18.3亿美元，2024-2031年预测期间复合年增长率为6.4%。

麻醉一次性用品是一类一次性医疗产品，主要用于在外科手术过程中使用麻醉剂。这些物品对于确保病人安全、防止交叉污染和维持手术室无菌环境至关重要。最常见的麻醉一次性用品是麻醉呼吸迴路、气管插管、麻醉面罩和喉罩。这些组件中的每一个对于麻醉剂的成功输送以及手术期间气道管理和监测的促进至关重要。

慢性病盛行率的增加是预测期内推动市场的驱动因素。例如，根据泛美卫生组织的数据，全球预计将有 2,000 万人新诊断癌症，1,000 万人因癌症死亡。未来二十年，癌症负担将增加近 60%，给医疗保健系统、个人和社区带来进一步的负担。

市场动态：

驱动程式和限制

慢性病盛行率增加

癌症盛行率的增加预计将成为全球麻醉一次性用品市场成长的重要因素。慢性病日益普及预计将对全球麻醉一次性用品市场产生重大影响。糖尿病、高血压、心血管疾病和呼吸系统疾病等慢性疾病经常需要进行外科手术，导致麻醉产品的需求增加。患有这些慢性疾病的患者在手术期间会遇到明显的问题，因为他们的健康状况会损害围手术期。例如，患有糖尿病的人可能会出现伤口癒合延迟和更容易感染的情况，而患有心血管疾病的人在手术前后出现併发症的风险更高。这种复杂性需要专家的麻醉管理，这增加了对一次性麻醉设备的需求，以确保这些高风险患者的安全性和有效性。

例如，根据美国国立卫生研究院的数据，到 2023 年，美国预计将出现 1,958,310 例新癌症病例和 609,820 例癌症死亡病例。前列腺癌发生率在经历了二十年的下降之后，从 2014 年到 2019 年每年上升 3%，导致新病例增加 99,000 例。年癌症发生率为每 10 万名男性和女性 440.5 例（基于 2017 年至 2021 年的病例）。癌症死亡率（癌症死亡率）为每年每 10 万名男性和女性 146.0 人（基于 2018 年至 2022 年的死亡人数）。到 2024 年，预计将有 14,910 名 0 至 19 岁的儿童和青少年被诊断出患有癌症，其中 1,590 人因此死亡。

此外，根据美国国立卫生研究院的数据，约有 4.62 亿人患有第 2 型糖尿病，相当于世界人口的 6.28%。例如，根据美国疾病管制与预防中心的数据，大约有 3,840 万各个年龄层的人（占美国人口的 11.6%）被诊断出患有糖尿病。在18岁及以上的成年人中，这一数字上升至3,810万，占美国成年人总数的14.7%。

缺乏训练有素的麻醉师

缺乏训练有素的麻醉师等因素预计将阻碍全球麻醉一次性市场的发展。训练有素的麻醉师和经过认证的註册护理麻醉师 (CRNA) 的日益缺乏预计将对全球麻醉一次性用品行业产生重大影响。这种稀缺性是由多种变数引起的多维度问题，包括劳动力老化和手术需求不断增长。由于医疗机构努力维持麻醉科适当的人员配备水平，提供及时有效的手术护理的能力受到影响，这对麻醉一次性消耗产生直接影响。

Anesthetic disposables are a category of single-use medical products created primarily for the administration of anesthetic during surgical procedures. These items are critical to guaranteeing patient safety, preventing cross-contamination, and maintaining a sterile environment in operating rooms. The most common forms of anesthetic disposables are anesthesia breathing circuits, endotracheal tubes, anesthesia masks, and laryngeal mask airways. Each of these components is critical to the successful delivery of anesthetic agents as well as the facilitation of airway management and monitoring during surgery.

The increasing prevalence of chronic diseases is the driving factor that drives the market over the forecast period. For instance, according to the Pan American Health Organization, globally, there were an expected 20 million new cancer diagnoses and 10 million cancer deaths. Over the next two decades, the cancer burden will rise by almost 60%, putting a further burden on healthcare systems, individuals, and communities.

Market Dynamics: Drivers & Restraints

Increasing prevalence of chronic diseases

The increasing prevalence of cancer is expected to be a significant factor in the growth of the global anesthesia disposables market. The increasing prevalence of chronic diseases is expected to have a substantial impact on the global anesthesia disposables market. Chronic ailments such as diabetes, hypertension, cardiovascular disease, and respiratory disorders frequently necessitate surgical procedures, resulting in increased demand for anesthetic products. Patients with these chronic disorders have distinct problems during surgery since their health can impair the perioperative procedure. Individuals with diabetes, for example, may experience delayed wound healing and greater susceptibility to infections, while those with cardiovascular disorders are at a higher risk of complications before and after surgery. This intricacy needs expert anesthetic management, which increases the demand for disposable anesthesia equipment that ensures safety and efficacy in these high-risk patients.

For instance, according to the National Institute of Health, in 2023, the United States is expected to see 1,958,310 new cancer cases and 609,820 cancer deaths. Prostate cancer incidence climbed by 3% every year from 2014 to 2019, after two decades of reduction, resulting in an additional 99,000 new cases. The annual cancer incidence rate is 440.5 per 100,000 men and women (based on cases from 2017 to 2021). The cancer death rate (cancer mortality) is 146.0 per 100,000 men and women annually (based on deaths from 2018-2022). In 2024, a projected 14,910 children and adolescents between the ages of 0 and 19 will be diagnosed with cancer, with 1,590 deaths from the condition.

Moreover, according to the National Institute of Health, approximately 462 million individuals were affected by type 2 diabetes corresponding to 6.28% of the world's population. For instance, according to the Centers for Disease Control and Prevention, approximately 38.4 million individuals of all ages, representing 11.6% of the U.S. population, were diagnosed with diabetes. Among adults aged 18 and older, this figure rose to 38.1 million, accounting for 14.7% of all U.S. adults.

Dearth of trained anaesthesiologists

Factors such as dearth of trained anaesthesiologists are expected to hamper the global anesthesia disposable market. The growing dearth of trained anesthesiologists and certified registered nurse anesthetists (CRNAs) is predicted to have a substantial impact on the worldwide anesthesia disposables industry. This scarcity is a multidimensional issue caused by a number of variables, including an aging workforce and a growing demand for surgery. As healthcare organizations struggle to maintain proper staffing levels in anesthesia departments, the capacity to offer timely and effective surgical care suffers, which has a direct impact on anesthesia disposable consumption.

Segment Analysis

The global anesthesia disposables market is segmented based on product, material, patient group, end user, and region.

Anaesthesia masks segment is expected to dominate the global anesthesia disposables market share

Anaesthesia masks segment is expected to dominate the global anesthesia disposables market share. The anesthesia masks segment is expected to dominate the worldwide anesthesia disposables market due to many compelling considerations that highlight its importance in surgical operations. Anesthesia masks, which are required for administering anesthetic gases and regulating patient breathing, are widely used in a variety of healthcare settings, including hospitals and ambulatory surgical centers. Their critical role in assuring patient safety and comfort during anesthetic administration makes them necessary in modern medical practice.

One of the key drivers of growth in the anesthesia masks industry is the growing number of surgical procedures conducted around the world and the increasing prevalence of chronic diseases. With advances in medical technology and an aging population necessitating surgical operations, the demand for effective anesthetic administration systems has increased. Anesthesia masks provide rapid and efficient ventilation, which is especially important in emergency situations and for patients undergoing short-term procedures. The shift to minimally invasive surgical techniques also contributes to this trend, as these operations frequently necessitate accurate and dependable anesthetic care, reinforcing the importance of anesthesia masks.

The increasing prevalence of chronic diseases results in an increase in the number of surgical procedures which increases the demand for anesthesia masks. For instance, according to the World Health Organization (WHO), cancer diagnoses are predicted to exceed 22 million by 2023 and in the case of breast cancer, 1 in 12 women will be diagnosed with breast cancer in their lifetime and 1 in 71 women die of it.

Geographical Analysis

North America is expected to hold a significant position in the global anesthesia disposables market share

North America is expected to maintain its dominant position in the global anesthetic disposables market due to several key factors. One significant driver is the region's high prevalence of chronic diseases, which results in an increasing number of surgical procedures. Conditions such as cardiovascular diseases, cancer, diabetes, and respiratory disorders are common, leading to a higher volume of procedures that require effective anesthetic management. Consequently, the demand for disposable anesthetic devices-including masks, tubes, and breathing circuits-continues to rise.

For example, according to the National Institutes of Health, the United States is projected to see 2,001,140 new cancer cases and 611,720 cancer-related deaths in 2024. While cancer mortality has decreased overall due to reductions in smoking, earlier detection, and improved treatments, this progress is being overshadowed by a rising incidence of six of the top ten cancers. This growing demand for surgical interventions and anesthetic management will further fuel the need for anesthetic disposables in the region.

Asia Pacific is growing at the fastest pace in the global anesthesia disposables market

Asia Pacific is experiencing the fastest growth in global anesthesia disposables owing to the increasing incidence of chronic diseases in the region. Asia Pacific experiences the greatest growth in the worldwide anesthetic disposables market, owing to a combination of variables that improve surgical capabilities and healthcare access throughout the region. One of the key drivers of this expansion is the increased volume of surgical procedures, which is mostly due to the rising prevalence of chronic conditions. As populations in nations like as China and India age and urbanize, there is an increase in health problems that necessitate surgical procedures. This trend calls for a higher dependence on anesthesia disposables as healthcare providers strive to assure patient safety and reduce infection risks during surgeries. For instance, according to the National Institute of Health, the expected number of cancer cases in India for 2022 is 14,61,427 (crude rate: 100.4 per 100,000). In India, one out of every nine people is likely to develop cancer over his or her lifetime. Males and females were most likely to develop lung and breast cancer, respectively.

Competitive Landscape

The major global players in the global anesthesia disposables market include Ambu A/S, Dragerwerk AG & Co. KGaA, Teleflex Incorporated, Hamilton Medical, Intersurgical Ltd, Medline Industries, LP, Medtronic, Mercury Medical, Sharn Anesthesia, Narang Medical Limited among others.

Emerging Players

Conus Airway, Solvet among others

Why Purchase the Report?

Pipeline & Innovations: Reviews ongoing clinical trials, product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
Product Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
Post-market Surveillance: Uses post-market data to enhance product safety and access.
Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The global anesthesia disposables market report would provide approximately 53 tables, 47 figures, and 176 pages.

Target Audience 2023

Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
Technology & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
Supply Chain: Distribution and Supply Chain Managers.
Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
Academic & Research: Academic Institutions.

1. Methodology and Scope

1.1. Research Methodology
1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

3.1. Snippet by Product
3.2. Snippet by Material
3.3. Snippet by Patient Group
3.4. Snippet by End User
3.5. Snippet by Region

4. Dynamics

4.1. Impacting Factors
- 4.1.1. Drivers
  - 4.1.1.1. Increasing Prevalence of Chronic Diseases
- 4.1.2. Restraints
  - 4.1.2.1. Dearth Of Trained Anaesthesiologists
- 4.1.3. Opportunity
- 4.1.4. Impact Analysis

5. Industry Analysis

5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
5.5. Reimbursement Analysis
5.6. Patent Analysis
5.7. SWOT Analysis
5.8. DMI Opinion

6. By Product

6.1. Introduction
- 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
- 6.1.2. Market Attractiveness Index, By Product
6.2. Laryngoscope*
- 6.2.1. Introduction
- 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
6.3. Resuscitators
6.4. Anaesthesia Masks
6.5. Breathing Bags
6.6. Breathing Circuits
6.7. Endotracheal Tubes
6.8. Intubation Accessories
6.9. Laryngeal Mask Airways

7. By Material

7.1. Introduction
- 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
- 7.1.2. Market Attractiveness Index, By Material
7.2. Plastic*
- 7.2.1. Introduction
- 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Silicone

8. By Patient Group

8.1. Introduction
- 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Patient Group
- 8.1.2. Market Attractiveness Index, By Patient Group
8.2. Neonatal*
- 8.2.1. Introduction
- 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Adult
8.4. Paediatric

9. By End User

9.1. Introduction
- 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 9.1.2. Market Attractiveness Index, By End User
9.2. Hospitals and Clinics*
- 9.2.1. Introduction
- 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Ambulatory Surgical Centers
9.4. Home Care Settings
9.5. Others

10. By Region

10.1. Introduction
- 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
- 10.1.2. Market Attractiveness Index, By Region
10.2. North America
- 10.2.1. Introduction
- 10.2.2. Key Region-Specific Dynamics
- 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
- 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
- 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Patient Group
- 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 10.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.2.7.1. The U.S.
  - 10.2.7.2. Canada
  - 10.2.7.3. Mexico
10.3. Europe
- 10.3.1. Introduction
- 10.3.2. Key Region-Specific Dynamics
- 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
- 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
- 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Patient Group
- 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 10.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.3.7.1. Germany
  - 10.3.7.2. UK
  - 10.3.7.3. France
  - 10.3.7.4. Italy
  - 10.3.7.5. Spain
  - 10.3.7.6. Rest of Europe
10.4. South America
- 10.4.1. Introduction
- 10.4.2. Key Region-Specific Dynamics
- 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
- 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
- 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Patient Group
- 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 10.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.4.7.1. Brazil
  - 10.4.7.2. Argentina
  - 10.4.7.3. Rest of South America
10.5. Asia-Pacific
- 10.5.1. Introduction
- 10.5.2. Key Region-Specific Dynamics
- 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
- 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
- 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Patient Group
- 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 10.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.5.7.1. China
  - 10.5.7.2. India
  - 10.5.7.3. Japan
  - 10.5.7.4. South Korea
  - 10.5.7.5. Rest of Asia-Pacific
10.6. Middle East and Africa
- 10.6.1. Introduction
- 10.6.2. Key Region-Specific Dynamics
- 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
- 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
- 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Patient Group
- 10.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User

11. Competitive Landscape

11.1. Competitive Scenario
11.2. Market Positioning/Share Analysis
11.3. Mergers and Acquisitions Analysis

12. Company Profiles

12.1. Ambu A/S*
- 12.1.1. Company Overview
- 12.1.2. Product Portfolio and Description
- 12.1.3. Financial Overview
- 12.1.4. Key Developments
12.2. Dragerwerk AG & Co. KGaA
12.3. Teleflex Incorporated
12.4. Hamilton Medical
12.5. Intersurgical Ltd
12.6. Medline Industries, LP
12.7. Medtronic
12.8. Mercury Medical
12.9. Sharn Anesthesia
12.10. Narang Medical Limited

LIST NOT EXHAUSTIVE